With profound sadness and utmost respect, we announce the passing of Chair Professor Tien-Lu Cheng, Co-Founder and Chief Scientist of PrecisemAb Biotech.

 

Professor Cheng was the inventor of PrecisemAb’s Universal Antibody Lock technology and a trailblazer in antibody research, contributing over 30 years of expertise and innovation. He was critical in developing antibody therapeutics and successfully led numerous technology transfers. His exceptional academic achievements and innovative contributions have laid the foundation for many of PrecisemAb’s milestones. Today, the Antibody Lock technology has matured, transitioning from academic discovery to industrial application, offering transformative potential for the medical field.

 

The PrecisemAb team is deeply committed to continuing Professor Cheng’s mission and honoring his legacy. We will focus on advancing innovative drug development, strengthening collaborations, and promoting the Antibody Lock technology to deliver impactful solutions for society.

 

We extend our heartfelt condolences to Professor Cheng’s family. We are deeply grateful for his invaluable contributions to science and PrecisemAb Biotech. His wisdom, passion, and dedication will remain forever in our hearts, guiding us as we strive to realize his vision.

 

PrecisemAb Biotech